Skip to main content

Modern and Collaborative Approaches to Dry Eye Disease Diagnosis, Treatment, and Management - Tuesday, December 8, 2020

CME/CE Webinar

Tuesday, December 8, 2020
5:00 PM PST | 6:00 PM MST| 7:00 PM CST| 8:00 PM EST


NOTE: You will be asked to "sign in" or "sign up" to register for the program and then complete a brief pretest. Once you submit your answers, choose "next item". Upon registration, a link to access the webinar will be sent in a confirmation email.

Please contact with any questions. Thank you!

Click HERE for a downloadable patient education brochure on dry eye disease.


Kendall E. Donaldson, MD, MS (Co-Chair)
Professor of Clinical Ophthalmology
Medical Director
Bascom Palmer Eye Institute in Plantation
Plantation, Florida

Walter O. Whitley, OD, MBA, FAAO (Co-Chair)
Director, Optometric Services
Virginia Eye Consultants
Virginia Beach, Virginia


Target Audience
This educational activity intends to educate ophthalmologists and optometrists.

Learning Objectives
Upon completion of this activity, participants will be better able to:
  • Recognize factors that influence the evolving prevalence of dry eye disease 
  • Select appropriate tests for diagnosing dry eye disease
  • Describe the implications of inflammation in dry eye disease on treatment
  • Select the most appropriate treatment regimen for individual patients with dry eye disease
  • Incorporate education regularly into patient encounters

Accreditation Statement
The New York Eye and Ear Infirmary of Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This educational activity was developed and implemented in collaboration with MedEdicus LLC.

AMA Credit Designation Statement
The New York Eye and Ear Infirmary of Mount Sinai designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

COPE approved for 1.0 CE credit for optometrists 
COPE Course ID: 70402-AS (Interactive Distance Learning Course)
COPE Course Category: Treatment & Management of Ocular Disease: Anterior Segment (AS)


Sponsored by

Grantor Statement
This continuing medical education activity is supported through an unrestricted educational grant from Novartis Pharmaceuticals Corporation.

Disclosure Policy Statement
It is the policy of New York Eye and Ear Infirmary of Mount Sinai that the faculty and anyone in a position to control activity content disclose any real or apparent conflicts of interest relating to the topics of the educational activity in which they are participating. They are also required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. New York Eye and Ear Infirmary of Mount Sinai is committed to providing its learners with quality CME activities and related materials that promote improvements in healthcare and not the proprietary interests of a commercial interest and, thus, has established policies and procedures in place that identify and resolve all conflicts of interest prior to the execution or release of its educational activities. Full disclosure of faculty/planners and their commercial relationships, if any, follows.

Kendall E. Donaldson, MD, MS, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Alcon; Allergan; Bausch & Lomb Incorporated; Dompé US, Inc; Eyevance; Johnson & Johnson Vision Care, Inc; Kala Pharmaceuticals; Lumenis; Omeros Corporation; TissueTech, Inc; and Zeiss.

Walter O. Whitley, OD, MBA, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Aerie Pharmaceuticals, Inc; Alcon; Allergan; Bausch & Lomb Incorporated; Bio-Tissue; Bruder Healthcare; Eyevance; Glaukos Corporation; Horizon Therapeutics plc; Johnson & Johnson Vision Care, Inc; Kala Pharmaceuticals; Notal Vision; Novartis Pharmaceuticals Corporation; Ocular Therapeutix, Inc; OCuSOFT Inc; Oyster Point Pharma, Inc; Quidel Corporation; Regener-Eyes; RVL Pharmaceuticals, Inc; ScienceBased Health; Sun Pharmaceutical Industries, Inc; Tarsus Pharmaceuticals, Inc; TearLab Corporation; and Thea Pharmaceuticals Limited; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Aerie Pharmaceuticals, Inc; Alcon; Bausch & Lomb Incorporated; Bio-Tissue; Eyevance; Novartis Pharmaceuticals Corporation; ScienceBased Health; and Sun Pharmaceutical Industries, Inc; Ownership Interest (Stock options, or other holdings, excluding diversified mutual funds): Leo Lens Technology, Inc.

New York Eye and Ear Infirmary of Mount Sinai Peer Reviewer Disclosure

Priti Batta, MD, has no relevant commercial relationships to disclose.

Editorial Support Disclosures

Melissa Carter, MS; Cynthia Tornallyay, RD, MBA, CHCP; Barbara Aubel; and Michelle Ong have no relevant commercial relationships to disclose.

Disclosure Attestation
The contributing physicians listed above have attested to the following:
  1. that the relationships/affiliations noted will not bias or otherwise influence their involvement in this activity;
  2. that practice recommendations given relevant to the companies with whom they have relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and
  3. that all reasonable clinical alternatives will be discussed when making practice recommendations.

Off-Label Discussion

This CME/CE activity includes discussion of unlabeled and/or investigative uses of drugs. Please refer to the official prescribing information for each drug discussed in this activity for FDA-approved dosing, indications, and warnings.

New York Eye and Ear Infirmary of Mount Sinai Privacy & Confidentiality Policies

CME Provider Contact Information
For questions about this activity, call 917-270-7571 or contact Kim Sponza at 203-461-0222.

To Obtain CME/CE Credit
To obtain CME/CE credit for this activity, view the webinar in its entirety and consult referenced sources as necessary. Please take the post test and evaluation online. Upon registering and successfully completing the post test, your certificate will be made available online and you can print it or file it.

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of New York Eye and Ear Infirmary of Mount Sinai, MedEdicus LLC, or Novartis Pharmaceuticals Corporation.

This CME/CE activity is copyrighted to MedEdicus LLC ©2020. All rights reserved. 236